Deltex Medical Regulatory News (DEMG)

27 Oct 2005 15:33

Deltex Medical Group PLC27 October 2005 Deltex Medical Group plc Directors' Shareholdings 27 October 2005: Deltex Medical Group plc ("the Company"), the AIM listedhaemodynamic monitoring company, announces that the Chairman, Nigel Keen, hasnotified the Company of a purchase of 263,158 ordinary shares at a price of19.25 pence per share. Following the above purchase, the directors' beneficial interests are asfollows: Name of Director Number of shares Holding of shares % of enlarged issued purchased on market following issue/ share capital purchase Nigel Keen (1) 263,158 4,126,884 5.67%Dr Edwin Snape (2) - 3,164,074 4.35%Peter Smedvig (3) - 1,098,439 1.51%Andy Hill - 42,857 0.06%Ewan Phillips - 714,656 0.99%George Flouty - 244,671 0.34%Sir Duncan Nichol - 36,947 0.05% Total 263,158 9,428,528 12.97% (1) Includes 589,700 shares held as trustee and executor of Pauline ThomasCharity Will Trust. (2) Includes shares held as a director of New England Partners and associatedcompanies. (3) Includes shares held as director of Peder Smedvig Capital AS. For further information, please contact:- Deltex Medical Group plc 01243 774 837Nigel Keen, Chairman nigel.keen@deltexmedical.comAndy Hill, Chief Executive andy.hill@deltexmedical.comEwan Phillips, Finance Director ewan.phillips@deltexmedical.com Charles Stanley 0207 953 2000Philip Davies Financial DynamicsDavid Yates/John Gilbert 0207 831 3113 This information is provided by RNS The company news service from the London Stock Exchange